Medical Care
Global hERG Screening Market Research Report 2025
- Jun 28, 25
- ID: 346233
- Pages: 96
- Figures: 96
- Views: 61
The global market for hERG Screening was valued at US$ 1186 million in the year 2024 and is projected to reach a revised size of US$ 2627 million by 2031, growing at a CAGR of 12.2% during the forecast period.
HERG screening has been an important component of cardiac safety-pharmacology from the past many years. hERG was identified as a potassium-selective cardiac ion channel, Kv11.1, which plays an important role during cardiac repolarization.
Due to the growth in instances of cardiotoxicity, there has been a significant demand for screening the materials used in pharmaceutical production.
This report aims to provide a comprehensive presentation of the global market for hERG Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding hERG Screening.
The hERG Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global hERG Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the hERG Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories
Eurofins Scientific
Merck KGaA
Cyprotex Limited
BSYS GmbH
Creative bioarray
Metrion biosciences
Aurora Biomed
Charles River Laboratories
Eurofins Scientific
Merck KGaA
Cyprotex Limited
BSYS GmbH
Creative bioarray
Metrion biosciences
Aurora Biomed
Segment by Type
Gene KCNH2
Mutant KCNH2
Gene KCNH2
Mutant KCNH2
Segment by Application
Antiarrhythmic
Antipsychotic
Antibiotics
Others
Antiarrhythmic
Antipsychotic
Antibiotics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of hERG Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
HERG screening has been an important component of cardiac safety-pharmacology from the past many years. hERG was identified as a potassium-selective cardiac ion channel, Kv11.1, which plays an important role during cardiac repolarization.
Due to the growth in instances of cardiotoxicity, there has been a significant demand for screening the materials used in pharmaceutical production.
This report aims to provide a comprehensive presentation of the global market for hERG Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding hERG Screening.
The hERG Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global hERG Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the hERG Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories
Eurofins Scientific
Merck KGaA
Cyprotex Limited
BSYS GmbH
Creative bioarray
Metrion biosciences
Aurora Biomed
Charles River Laboratories
Eurofins Scientific
Merck KGaA
Cyprotex Limited
BSYS GmbH
Creative bioarray
Metrion biosciences
Aurora Biomed
Segment by Type
Gene KCNH2
Mutant KCNH2
Gene KCNH2
Mutant KCNH2
Segment by Application
Antiarrhythmic
Antipsychotic
Antibiotics
Others
Antiarrhythmic
Antipsychotic
Antibiotics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of hERG Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global hERG Screening Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Gene KCNH2
1.2.3 Mutant KCNH2
1.2.4 Gene KCNH2
1.2.5 Mutant KCNH2
1.3 Market by Application
1.3.1 Global hERG Screening Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Antiarrhythmic
1.3.3 Antipsychotic
1.3.4 Antibiotics
1.3.5 Others
1.3.6 Antiarrhythmic
1.3.7 Antipsychotic
1.3.8 Antibiotics
1.3.9 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global hERG Screening Market Perspective (2020-2031)
2.2 Global hERG Screening Growth Trends by Region
2.2.1 Global hERG Screening Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 hERG Screening Historic Market Size by Region (2020-2025)
2.2.3 hERG Screening Forecasted Market Size by Region (2026-2031)
2.3 hERG Screening Market Dynamics
2.3.1 hERG Screening Industry Trends
2.3.2 hERG Screening Market Drivers
2.3.3 hERG Screening Market Challenges
2.3.4 hERG Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top hERG Screening Players by Revenue
3.1.1 Global Top hERG Screening Players by Revenue (2020-2025)
3.1.2 Global hERG Screening Revenue Market Share by Players (2020-2025)
3.2 Global hERG Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by hERG Screening Revenue
3.4 Global hERG Screening Market Concentration Ratio
3.4.1 Global hERG Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by hERG Screening Revenue in 2024
3.5 Global Key Players of hERG Screening Head office and Area Served
3.6 Global Key Players of hERG Screening, Product and Application
3.7 Global Key Players of hERG Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 hERG Screening Breakdown Data by Type
4.1 Global hERG Screening Historic Market Size by Type (2020-2025)
4.2 Global hERG Screening Forecasted Market Size by Type (2026-2031)
5 hERG Screening Breakdown Data by Application
5.1 Global hERG Screening Historic Market Size by Application (2020-2025)
5.2 Global hERG Screening Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America hERG Screening Market Size (2020-2031)
6.2 North America hERG Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America hERG Screening Market Size by Country (2020-2025)
6.4 North America hERG Screening Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe hERG Screening Market Size (2020-2031)
7.2 Europe hERG Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe hERG Screening Market Size by Country (2020-2025)
7.4 Europe hERG Screening Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific hERG Screening Market Size (2020-2031)
8.2 Asia-Pacific hERG Screening Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific hERG Screening Market Size by Region (2020-2025)
8.4 Asia-Pacific hERG Screening Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America hERG Screening Market Size (2020-2031)
9.2 Latin America hERG Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America hERG Screening Market Size by Country (2020-2025)
9.4 Latin America hERG Screening Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa hERG Screening Market Size (2020-2031)
10.2 Middle East & Africa hERG Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa hERG Screening Market Size by Country (2020-2025)
10.4 Middle East & Africa hERG Screening Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Details
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories hERG Screening Introduction
11.1.4 Charles River Laboratories Revenue in hERG Screening Business (2020-2025)
11.1.5 Charles River Laboratories Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Details
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific hERG Screening Introduction
11.2.4 Eurofins Scientific Revenue in hERG Screening Business (2020-2025)
11.2.5 Eurofins Scientific Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA hERG Screening Introduction
11.3.4 Merck KGaA Revenue in hERG Screening Business (2020-2025)
11.3.5 Merck KGaA Recent Development
11.4 Cyprotex Limited
11.4.1 Cyprotex Limited Company Details
11.4.2 Cyprotex Limited Business Overview
11.4.3 Cyprotex Limited hERG Screening Introduction
11.4.4 Cyprotex Limited Revenue in hERG Screening Business (2020-2025)
11.4.5 Cyprotex Limited Recent Development
11.5 BSYS GmbH
11.5.1 BSYS GmbH Company Details
11.5.2 BSYS GmbH Business Overview
11.5.3 BSYS GmbH hERG Screening Introduction
11.5.4 BSYS GmbH Revenue in hERG Screening Business (2020-2025)
11.5.5 BSYS GmbH Recent Development
11.6 Creative bioarray
11.6.1 Creative bioarray Company Details
11.6.2 Creative bioarray Business Overview
11.6.3 Creative bioarray hERG Screening Introduction
11.6.4 Creative bioarray Revenue in hERG Screening Business (2020-2025)
11.6.5 Creative bioarray Recent Development
11.7 Metrion biosciences
11.7.1 Metrion biosciences Company Details
11.7.2 Metrion biosciences Business Overview
11.7.3 Metrion biosciences hERG Screening Introduction
11.7.4 Metrion biosciences Revenue in hERG Screening Business (2020-2025)
11.7.5 Metrion biosciences Recent Development
11.8 Aurora Biomed
11.8.1 Aurora Biomed Company Details
11.8.2 Aurora Biomed Business Overview
11.8.3 Aurora Biomed hERG Screening Introduction
11.8.4 Aurora Biomed Revenue in hERG Screening Business (2020-2025)
11.8.5 Aurora Biomed Recent Development
11.9 Charles River Laboratories
11.9.1 Charles River Laboratories Company Details
11.9.2 Charles River Laboratories Business Overview
11.9.3 Charles River Laboratories hERG Screening Introduction
11.9.4 Charles River Laboratories Revenue in hERG Screening Business (2020-2025)
11.9.5 Charles River Laboratories Recent Development
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Company Details
11.10.2 Eurofins Scientific Business Overview
11.10.3 Eurofins Scientific hERG Screening Introduction
11.10.4 Eurofins Scientific Revenue in hERG Screening Business (2020-2025)
11.10.5 Eurofins Scientific Recent Development
11.11 Merck KGaA
11.11.1 Merck KGaA Company Details
11.11.2 Merck KGaA Business Overview
11.11.3 Merck KGaA hERG Screening Introduction
11.11.4 Merck KGaA Revenue in hERG Screening Business (2020-2025)
11.11.5 Merck KGaA Recent Development
11.12 Cyprotex Limited
11.12.1 Cyprotex Limited Company Details
11.12.2 Cyprotex Limited Business Overview
11.12.3 Cyprotex Limited hERG Screening Introduction
11.12.4 Cyprotex Limited Revenue in hERG Screening Business (2020-2025)
11.12.5 Cyprotex Limited Recent Development
11.13 BSYS GmbH
11.13.1 BSYS GmbH Company Details
11.13.2 BSYS GmbH Business Overview
11.13.3 BSYS GmbH hERG Screening Introduction
11.13.4 BSYS GmbH Revenue in hERG Screening Business (2020-2025)
11.13.5 BSYS GmbH Recent Development
11.14 Creative bioarray
11.14.1 Creative bioarray Company Details
11.14.2 Creative bioarray Business Overview
11.14.3 Creative bioarray hERG Screening Introduction
11.14.4 Creative bioarray Revenue in hERG Screening Business (2020-2025)
11.14.5 Creative bioarray Recent Development
11.15 Metrion biosciences
11.15.1 Metrion biosciences Company Details
11.15.2 Metrion biosciences Business Overview
11.15.3 Metrion biosciences hERG Screening Introduction
11.15.4 Metrion biosciences Revenue in hERG Screening Business (2020-2025)
11.15.5 Metrion biosciences Recent Development
11.16 Aurora Biomed
11.16.1 Aurora Biomed Company Details
11.16.2 Aurora Biomed Business Overview
11.16.3 Aurora Biomed hERG Screening Introduction
11.16.4 Aurora Biomed Revenue in hERG Screening Business (2020-2025)
11.16.5 Aurora Biomed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global hERG Screening Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Gene KCNH2
1.2.3 Mutant KCNH2
1.2.4 Gene KCNH2
1.2.5 Mutant KCNH2
1.3 Market by Application
1.3.1 Global hERG Screening Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Antiarrhythmic
1.3.3 Antipsychotic
1.3.4 Antibiotics
1.3.5 Others
1.3.6 Antiarrhythmic
1.3.7 Antipsychotic
1.3.8 Antibiotics
1.3.9 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global hERG Screening Market Perspective (2020-2031)
2.2 Global hERG Screening Growth Trends by Region
2.2.1 Global hERG Screening Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 hERG Screening Historic Market Size by Region (2020-2025)
2.2.3 hERG Screening Forecasted Market Size by Region (2026-2031)
2.3 hERG Screening Market Dynamics
2.3.1 hERG Screening Industry Trends
2.3.2 hERG Screening Market Drivers
2.3.3 hERG Screening Market Challenges
2.3.4 hERG Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top hERG Screening Players by Revenue
3.1.1 Global Top hERG Screening Players by Revenue (2020-2025)
3.1.2 Global hERG Screening Revenue Market Share by Players (2020-2025)
3.2 Global hERG Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by hERG Screening Revenue
3.4 Global hERG Screening Market Concentration Ratio
3.4.1 Global hERG Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by hERG Screening Revenue in 2024
3.5 Global Key Players of hERG Screening Head office and Area Served
3.6 Global Key Players of hERG Screening, Product and Application
3.7 Global Key Players of hERG Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 hERG Screening Breakdown Data by Type
4.1 Global hERG Screening Historic Market Size by Type (2020-2025)
4.2 Global hERG Screening Forecasted Market Size by Type (2026-2031)
5 hERG Screening Breakdown Data by Application
5.1 Global hERG Screening Historic Market Size by Application (2020-2025)
5.2 Global hERG Screening Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America hERG Screening Market Size (2020-2031)
6.2 North America hERG Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America hERG Screening Market Size by Country (2020-2025)
6.4 North America hERG Screening Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe hERG Screening Market Size (2020-2031)
7.2 Europe hERG Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe hERG Screening Market Size by Country (2020-2025)
7.4 Europe hERG Screening Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific hERG Screening Market Size (2020-2031)
8.2 Asia-Pacific hERG Screening Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific hERG Screening Market Size by Region (2020-2025)
8.4 Asia-Pacific hERG Screening Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America hERG Screening Market Size (2020-2031)
9.2 Latin America hERG Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America hERG Screening Market Size by Country (2020-2025)
9.4 Latin America hERG Screening Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa hERG Screening Market Size (2020-2031)
10.2 Middle East & Africa hERG Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa hERG Screening Market Size by Country (2020-2025)
10.4 Middle East & Africa hERG Screening Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Details
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories hERG Screening Introduction
11.1.4 Charles River Laboratories Revenue in hERG Screening Business (2020-2025)
11.1.5 Charles River Laboratories Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Details
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific hERG Screening Introduction
11.2.4 Eurofins Scientific Revenue in hERG Screening Business (2020-2025)
11.2.5 Eurofins Scientific Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA hERG Screening Introduction
11.3.4 Merck KGaA Revenue in hERG Screening Business (2020-2025)
11.3.5 Merck KGaA Recent Development
11.4 Cyprotex Limited
11.4.1 Cyprotex Limited Company Details
11.4.2 Cyprotex Limited Business Overview
11.4.3 Cyprotex Limited hERG Screening Introduction
11.4.4 Cyprotex Limited Revenue in hERG Screening Business (2020-2025)
11.4.5 Cyprotex Limited Recent Development
11.5 BSYS GmbH
11.5.1 BSYS GmbH Company Details
11.5.2 BSYS GmbH Business Overview
11.5.3 BSYS GmbH hERG Screening Introduction
11.5.4 BSYS GmbH Revenue in hERG Screening Business (2020-2025)
11.5.5 BSYS GmbH Recent Development
11.6 Creative bioarray
11.6.1 Creative bioarray Company Details
11.6.2 Creative bioarray Business Overview
11.6.3 Creative bioarray hERG Screening Introduction
11.6.4 Creative bioarray Revenue in hERG Screening Business (2020-2025)
11.6.5 Creative bioarray Recent Development
11.7 Metrion biosciences
11.7.1 Metrion biosciences Company Details
11.7.2 Metrion biosciences Business Overview
11.7.3 Metrion biosciences hERG Screening Introduction
11.7.4 Metrion biosciences Revenue in hERG Screening Business (2020-2025)
11.7.5 Metrion biosciences Recent Development
11.8 Aurora Biomed
11.8.1 Aurora Biomed Company Details
11.8.2 Aurora Biomed Business Overview
11.8.3 Aurora Biomed hERG Screening Introduction
11.8.4 Aurora Biomed Revenue in hERG Screening Business (2020-2025)
11.8.5 Aurora Biomed Recent Development
11.9 Charles River Laboratories
11.9.1 Charles River Laboratories Company Details
11.9.2 Charles River Laboratories Business Overview
11.9.3 Charles River Laboratories hERG Screening Introduction
11.9.4 Charles River Laboratories Revenue in hERG Screening Business (2020-2025)
11.9.5 Charles River Laboratories Recent Development
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Company Details
11.10.2 Eurofins Scientific Business Overview
11.10.3 Eurofins Scientific hERG Screening Introduction
11.10.4 Eurofins Scientific Revenue in hERG Screening Business (2020-2025)
11.10.5 Eurofins Scientific Recent Development
11.11 Merck KGaA
11.11.1 Merck KGaA Company Details
11.11.2 Merck KGaA Business Overview
11.11.3 Merck KGaA hERG Screening Introduction
11.11.4 Merck KGaA Revenue in hERG Screening Business (2020-2025)
11.11.5 Merck KGaA Recent Development
11.12 Cyprotex Limited
11.12.1 Cyprotex Limited Company Details
11.12.2 Cyprotex Limited Business Overview
11.12.3 Cyprotex Limited hERG Screening Introduction
11.12.4 Cyprotex Limited Revenue in hERG Screening Business (2020-2025)
11.12.5 Cyprotex Limited Recent Development
11.13 BSYS GmbH
11.13.1 BSYS GmbH Company Details
11.13.2 BSYS GmbH Business Overview
11.13.3 BSYS GmbH hERG Screening Introduction
11.13.4 BSYS GmbH Revenue in hERG Screening Business (2020-2025)
11.13.5 BSYS GmbH Recent Development
11.14 Creative bioarray
11.14.1 Creative bioarray Company Details
11.14.2 Creative bioarray Business Overview
11.14.3 Creative bioarray hERG Screening Introduction
11.14.4 Creative bioarray Revenue in hERG Screening Business (2020-2025)
11.14.5 Creative bioarray Recent Development
11.15 Metrion biosciences
11.15.1 Metrion biosciences Company Details
11.15.2 Metrion biosciences Business Overview
11.15.3 Metrion biosciences hERG Screening Introduction
11.15.4 Metrion biosciences Revenue in hERG Screening Business (2020-2025)
11.15.5 Metrion biosciences Recent Development
11.16 Aurora Biomed
11.16.1 Aurora Biomed Company Details
11.16.2 Aurora Biomed Business Overview
11.16.3 Aurora Biomed hERG Screening Introduction
11.16.4 Aurora Biomed Revenue in hERG Screening Business (2020-2025)
11.16.5 Aurora Biomed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global hERG Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Gene KCNH2
Table 3. Key Players of Mutant KCNH2
Table 4. Key Players of Gene KCNH2
Table 5. Key Players of Mutant KCNH2
Table 6. Global hERG Screening Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global hERG Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global hERG Screening Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global hERG Screening Market Share by Region (2020-2025)
Table 10. Global hERG Screening Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global hERG Screening Market Share by Region (2026-2031)
Table 12. hERG Screening Market Trends
Table 13. hERG Screening Market Drivers
Table 14. hERG Screening Market Challenges
Table 15. hERG Screening Market Restraints
Table 16. Global hERG Screening Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global hERG Screening Market Share by Players (2020-2025)
Table 18. Global Top hERG Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in hERG Screening as of 2024)
Table 19. Ranking of Global Top hERG Screening Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by hERG Screening Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of hERG Screening, Headquarters and Area Served
Table 22. Global Key Players of hERG Screening, Product and Application
Table 23. Global Key Players of hERG Screening, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global hERG Screening Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global hERG Screening Revenue Market Share by Type (2020-2025)
Table 27. Global hERG Screening Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global hERG Screening Revenue Market Share by Type (2026-2031)
Table 29. Global hERG Screening Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global hERG Screening Revenue Market Share by Application (2020-2025)
Table 31. Global hERG Screening Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global hERG Screening Revenue Market Share by Application (2026-2031)
Table 33. North America hERG Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America hERG Screening Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America hERG Screening Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe hERG Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe hERG Screening Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe hERG Screening Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific hERG Screening Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific hERG Screening Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific hERG Screening Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America hERG Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America hERG Screening Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America hERG Screening Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa hERG Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa hERG Screening Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa hERG Screening Market Size by Country (2026-2031) & (US$ Million)
Table 48. Charles River Laboratories Company Details
Table 49. Charles River Laboratories Business Overview
Table 50. Charles River Laboratories hERG Screening Product
Table 51. Charles River Laboratories Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 52. Charles River Laboratories Recent Development
Table 53. Eurofins Scientific Company Details
Table 54. Eurofins Scientific Business Overview
Table 55. Eurofins Scientific hERG Screening Product
Table 56. Eurofins Scientific Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 57. Eurofins Scientific Recent Development
Table 58. Merck KGaA Company Details
Table 59. Merck KGaA Business Overview
Table 60. Merck KGaA hERG Screening Product
Table 61. Merck KGaA Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 62. Merck KGaA Recent Development
Table 63. Cyprotex Limited Company Details
Table 64. Cyprotex Limited Business Overview
Table 65. Cyprotex Limited hERG Screening Product
Table 66. Cyprotex Limited Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 67. Cyprotex Limited Recent Development
Table 68. BSYS GmbH Company Details
Table 69. BSYS GmbH Business Overview
Table 70. BSYS GmbH hERG Screening Product
Table 71. BSYS GmbH Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 72. BSYS GmbH Recent Development
Table 73. Creative bioarray Company Details
Table 74. Creative bioarray Business Overview
Table 75. Creative bioarray hERG Screening Product
Table 76. Creative bioarray Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 77. Creative bioarray Recent Development
Table 78. Metrion biosciences Company Details
Table 79. Metrion biosciences Business Overview
Table 80. Metrion biosciences hERG Screening Product
Table 81. Metrion biosciences Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 82. Metrion biosciences Recent Development
Table 83. Aurora Biomed Company Details
Table 84. Aurora Biomed Business Overview
Table 85. Aurora Biomed hERG Screening Product
Table 86. Aurora Biomed Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 87. Aurora Biomed Recent Development
Table 88. Charles River Laboratories Company Details
Table 89. Charles River Laboratories Business Overview
Table 90. Charles River Laboratories hERG Screening Product
Table 91. Charles River Laboratories Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 92. Charles River Laboratories Recent Development
Table 93. Eurofins Scientific Company Details
Table 94. Eurofins Scientific Business Overview
Table 95. Eurofins Scientific hERG Screening Product
Table 96. Eurofins Scientific Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 97. Eurofins Scientific Recent Development
Table 98. Merck KGaA Company Details
Table 99. Merck KGaA Business Overview
Table 100. Merck KGaA hERG Screening Product
Table 101. Merck KGaA Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 102. Merck KGaA Recent Development
Table 103. Cyprotex Limited Company Details
Table 104. Cyprotex Limited Business Overview
Table 105. Cyprotex Limited hERG Screening Product
Table 106. Cyprotex Limited Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 107. Cyprotex Limited Recent Development
Table 108. BSYS GmbH Company Details
Table 109. BSYS GmbH Business Overview
Table 110. BSYS GmbH hERG Screening Product
Table 111. BSYS GmbH Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 112. BSYS GmbH Recent Development
Table 113. Creative bioarray Company Details
Table 114. Creative bioarray Business Overview
Table 115. Creative bioarray hERG Screening Product
Table 116. Creative bioarray Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 117. Creative bioarray Recent Development
Table 118. Metrion biosciences Company Details
Table 119. Metrion biosciences Business Overview
Table 120. Metrion biosciences hERG Screening Product
Table 121. Metrion biosciences Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 122. Metrion biosciences Recent Development
Table 123. Aurora Biomed Company Details
Table 124. Aurora Biomed Business Overview
Table 125. Aurora Biomed hERG Screening Product
Table 126. Aurora Biomed Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 127. Aurora Biomed Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. hERG Screening Picture
Figure 2. Global hERG Screening Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global hERG Screening Market Share by Type: 2024 VS 2031
Figure 4. Gene KCNH2 Features
Figure 5. Mutant KCNH2 Features
Figure 6. Gene KCNH2 Features
Figure 7. Mutant KCNH2 Features
Figure 8. Global hERG Screening Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global hERG Screening Market Share by Application: 2024 VS 2031
Figure 10. Antiarrhythmic Case Studies
Figure 11. Antipsychotic Case Studies
Figure 12. Antibiotics Case Studies
Figure 13. Others Case Studies
Figure 14. Antiarrhythmic Case Studies
Figure 15. Antipsychotic Case Studies
Figure 16. Antibiotics Case Studies
Figure 17. Others Case Studies
Figure 18. hERG Screening Report Years Considered
Figure 19. Global hERG Screening Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 20. Global hERG Screening Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global hERG Screening Market Share by Region: 2024 VS 2031
Figure 22. Global hERG Screening Market Share by Players in 2024
Figure 23. Global Top hERG Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in hERG Screening as of 2024)
Figure 24. The Top 10 and 5 Players Market Share by hERG Screening Revenue in 2024
Figure 25. North America hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. North America hERG Screening Market Share by Country (2020-2031)
Figure 27. United States hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Canada hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Europe hERG Screening Market Share by Country (2020-2031)
Figure 31. Germany hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. France hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. U.K. hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Italy hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Russia hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Nordic Countries hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific hERG Screening Market Share by Region (2020-2031)
Figure 39. China hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Japan hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. South Korea hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Southeast Asia hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. India hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Australia hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Latin America hERG Screening Market Share by Country (2020-2031)
Figure 47. Mexico hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Brazil hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa hERG Screening Market Share by Country (2020-2031)
Figure 51. Turkey hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. UAE hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Charles River Laboratories Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 55. Eurofins Scientific Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 56. Merck KGaA Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 57. Cyprotex Limited Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 58. BSYS GmbH Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 59. Creative bioarray Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 60. Metrion biosciences Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 61. Aurora Biomed Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 62. Charles River Laboratories Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 63. Eurofins Scientific Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 64. Merck KGaA Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 65. Cyprotex Limited Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 66. BSYS GmbH Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 67. Creative bioarray Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 68. Metrion biosciences Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 69. Aurora Biomed Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Table 1. Global hERG Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Gene KCNH2
Table 3. Key Players of Mutant KCNH2
Table 4. Key Players of Gene KCNH2
Table 5. Key Players of Mutant KCNH2
Table 6. Global hERG Screening Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global hERG Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global hERG Screening Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global hERG Screening Market Share by Region (2020-2025)
Table 10. Global hERG Screening Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global hERG Screening Market Share by Region (2026-2031)
Table 12. hERG Screening Market Trends
Table 13. hERG Screening Market Drivers
Table 14. hERG Screening Market Challenges
Table 15. hERG Screening Market Restraints
Table 16. Global hERG Screening Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global hERG Screening Market Share by Players (2020-2025)
Table 18. Global Top hERG Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in hERG Screening as of 2024)
Table 19. Ranking of Global Top hERG Screening Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by hERG Screening Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of hERG Screening, Headquarters and Area Served
Table 22. Global Key Players of hERG Screening, Product and Application
Table 23. Global Key Players of hERG Screening, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global hERG Screening Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global hERG Screening Revenue Market Share by Type (2020-2025)
Table 27. Global hERG Screening Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global hERG Screening Revenue Market Share by Type (2026-2031)
Table 29. Global hERG Screening Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global hERG Screening Revenue Market Share by Application (2020-2025)
Table 31. Global hERG Screening Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global hERG Screening Revenue Market Share by Application (2026-2031)
Table 33. North America hERG Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America hERG Screening Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America hERG Screening Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe hERG Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe hERG Screening Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe hERG Screening Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific hERG Screening Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific hERG Screening Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific hERG Screening Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America hERG Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America hERG Screening Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America hERG Screening Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa hERG Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa hERG Screening Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa hERG Screening Market Size by Country (2026-2031) & (US$ Million)
Table 48. Charles River Laboratories Company Details
Table 49. Charles River Laboratories Business Overview
Table 50. Charles River Laboratories hERG Screening Product
Table 51. Charles River Laboratories Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 52. Charles River Laboratories Recent Development
Table 53. Eurofins Scientific Company Details
Table 54. Eurofins Scientific Business Overview
Table 55. Eurofins Scientific hERG Screening Product
Table 56. Eurofins Scientific Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 57. Eurofins Scientific Recent Development
Table 58. Merck KGaA Company Details
Table 59. Merck KGaA Business Overview
Table 60. Merck KGaA hERG Screening Product
Table 61. Merck KGaA Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 62. Merck KGaA Recent Development
Table 63. Cyprotex Limited Company Details
Table 64. Cyprotex Limited Business Overview
Table 65. Cyprotex Limited hERG Screening Product
Table 66. Cyprotex Limited Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 67. Cyprotex Limited Recent Development
Table 68. BSYS GmbH Company Details
Table 69. BSYS GmbH Business Overview
Table 70. BSYS GmbH hERG Screening Product
Table 71. BSYS GmbH Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 72. BSYS GmbH Recent Development
Table 73. Creative bioarray Company Details
Table 74. Creative bioarray Business Overview
Table 75. Creative bioarray hERG Screening Product
Table 76. Creative bioarray Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 77. Creative bioarray Recent Development
Table 78. Metrion biosciences Company Details
Table 79. Metrion biosciences Business Overview
Table 80. Metrion biosciences hERG Screening Product
Table 81. Metrion biosciences Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 82. Metrion biosciences Recent Development
Table 83. Aurora Biomed Company Details
Table 84. Aurora Biomed Business Overview
Table 85. Aurora Biomed hERG Screening Product
Table 86. Aurora Biomed Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 87. Aurora Biomed Recent Development
Table 88. Charles River Laboratories Company Details
Table 89. Charles River Laboratories Business Overview
Table 90. Charles River Laboratories hERG Screening Product
Table 91. Charles River Laboratories Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 92. Charles River Laboratories Recent Development
Table 93. Eurofins Scientific Company Details
Table 94. Eurofins Scientific Business Overview
Table 95. Eurofins Scientific hERG Screening Product
Table 96. Eurofins Scientific Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 97. Eurofins Scientific Recent Development
Table 98. Merck KGaA Company Details
Table 99. Merck KGaA Business Overview
Table 100. Merck KGaA hERG Screening Product
Table 101. Merck KGaA Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 102. Merck KGaA Recent Development
Table 103. Cyprotex Limited Company Details
Table 104. Cyprotex Limited Business Overview
Table 105. Cyprotex Limited hERG Screening Product
Table 106. Cyprotex Limited Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 107. Cyprotex Limited Recent Development
Table 108. BSYS GmbH Company Details
Table 109. BSYS GmbH Business Overview
Table 110. BSYS GmbH hERG Screening Product
Table 111. BSYS GmbH Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 112. BSYS GmbH Recent Development
Table 113. Creative bioarray Company Details
Table 114. Creative bioarray Business Overview
Table 115. Creative bioarray hERG Screening Product
Table 116. Creative bioarray Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 117. Creative bioarray Recent Development
Table 118. Metrion biosciences Company Details
Table 119. Metrion biosciences Business Overview
Table 120. Metrion biosciences hERG Screening Product
Table 121. Metrion biosciences Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 122. Metrion biosciences Recent Development
Table 123. Aurora Biomed Company Details
Table 124. Aurora Biomed Business Overview
Table 125. Aurora Biomed hERG Screening Product
Table 126. Aurora Biomed Revenue in hERG Screening Business (2020-2025) & (US$ Million)
Table 127. Aurora Biomed Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. hERG Screening Picture
Figure 2. Global hERG Screening Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global hERG Screening Market Share by Type: 2024 VS 2031
Figure 4. Gene KCNH2 Features
Figure 5. Mutant KCNH2 Features
Figure 6. Gene KCNH2 Features
Figure 7. Mutant KCNH2 Features
Figure 8. Global hERG Screening Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global hERG Screening Market Share by Application: 2024 VS 2031
Figure 10. Antiarrhythmic Case Studies
Figure 11. Antipsychotic Case Studies
Figure 12. Antibiotics Case Studies
Figure 13. Others Case Studies
Figure 14. Antiarrhythmic Case Studies
Figure 15. Antipsychotic Case Studies
Figure 16. Antibiotics Case Studies
Figure 17. Others Case Studies
Figure 18. hERG Screening Report Years Considered
Figure 19. Global hERG Screening Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 20. Global hERG Screening Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global hERG Screening Market Share by Region: 2024 VS 2031
Figure 22. Global hERG Screening Market Share by Players in 2024
Figure 23. Global Top hERG Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in hERG Screening as of 2024)
Figure 24. The Top 10 and 5 Players Market Share by hERG Screening Revenue in 2024
Figure 25. North America hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. North America hERG Screening Market Share by Country (2020-2031)
Figure 27. United States hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Canada hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Europe hERG Screening Market Share by Country (2020-2031)
Figure 31. Germany hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. France hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. U.K. hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Italy hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Russia hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Nordic Countries hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific hERG Screening Market Share by Region (2020-2031)
Figure 39. China hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Japan hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. South Korea hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Southeast Asia hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. India hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Australia hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Latin America hERG Screening Market Share by Country (2020-2031)
Figure 47. Mexico hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Brazil hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa hERG Screening Market Share by Country (2020-2031)
Figure 51. Turkey hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. UAE hERG Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Charles River Laboratories Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 55. Eurofins Scientific Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 56. Merck KGaA Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 57. Cyprotex Limited Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 58. BSYS GmbH Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 59. Creative bioarray Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 60. Metrion biosciences Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 61. Aurora Biomed Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 62. Charles River Laboratories Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 63. Eurofins Scientific Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 64. Merck KGaA Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 65. Cyprotex Limited Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 66. BSYS GmbH Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 67. Creative bioarray Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 68. Metrion biosciences Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 69. Aurora Biomed Revenue Growth Rate in hERG Screening Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232